Pharma and BioTech Daily

Week in review October 18th 2025


Listen Later

This Week in Review covers episodes from October 14 to October 17, featuring major developments in the pharmaceutical and biotech industries. Episodes included:

  • Biotech Breakthroughs: Partnerships, AI, and Clinical Triumphs
  • Pharma Breakthroughs: Advancing Cancer, Diabetes, and HIV Care
  • Navigating Regulatory Shifts and Strategic Mergers in Biotech
  • Revolutionizing Care: Key Biotech Breakthroughs and Trends

Key topics covered:

  • Strategic acquisitions and partnerships
  • Regulatory updates and FDA approvals
  • Clinical trial results and breakthroughs
  • Industry trends and market developments


Support the show

...more
View all episodesView all episodes
Download on the App Store

Pharma and BioTech DailyBy Pharma and BioTech News

  • 3.3
  • 3.3
  • 3.3
  • 3.3
  • 3.3

3.3

15 ratings


More shows like Pharma and BioTech Daily

View all
Exchanges by Goldman Sachs

Exchanges

977 Listeners

WSJ What’s News by The Wall Street Journal

WSJ What’s News

4,420 Listeners

Bloomberg Intelligence by Bloomberg

Bloomberg Intelligence

406 Listeners

Odd Lots by Bloomberg

Odd Lots

1,993 Listeners

WSJ Tech News Briefing by The Wall Street Journal

WSJ Tech News Briefing

1,649 Listeners

The Readout Loud by STAT

The Readout Loud

337 Listeners

Wall Street Breakfast by Seeking Alpha

Wall Street Breakfast

1,044 Listeners

FT News Briefing by Financial Times

FT News Briefing

684 Listeners

The Story of Money by Financial Times

The Story of Money

232 Listeners

Making Sense by J.P. Morgan

Making Sense

71 Listeners

Thoughts on the Market by Morgan Stanley

Thoughts on the Market

1,320 Listeners

The Journal. by The Wall Street Journal & Spotify Studios

The Journal.

6,097 Listeners

The World in Brief from The Economist by The Economist

The World in Brief from The Economist

1,089 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more

Biotech Hangout

21 Listeners

The Markets by Goldman Sachs

The Markets

80 Listeners